Charles River Laboratories International, Inc. CRL

Updated: 7 Sep 2026

NYSE | Biotech | Drug discovery and preclinical research

No signal published yet

We already track Charles River Laboratories International and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Charles River Laboratories International free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Drug discovery and preclinical research
We're already tracking Charles River Laboratories International, Inc. — here are the latest events we've registered

Recent News

  • On August 5, 2026, Charles River Laboratories reported second-quarter 2026 revenue of $1.00 billion and non-GAAP earnings per share of $3.02. The company recorded 0.1% organic revenue growth, marking its first quarterly organic expansion since the third quarter of 2023. Driven by recovering demand in its Discovery and Safety Assessment segment, management raised its full-year 2026 revenue and earnings guidance.

What Firelda Watch includes for Charles River Laboratories International, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Charles River Laboratories International, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Vicore Pharma Holding AB (publ)
VICO
HOLD
Cereno Scientific B
CRNO B
NEUTRAL
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD

Biotech

More companies in this sector

Want to follow Charles River Laboratories International, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Charles River Laboratories International free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Charles River Laboratories International, Inc. CRL
Charles River Laboratories International — follow and we'll monitor it
Follow Charles River Laboratories International free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.